BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37936360)

  • 1. [Health economic evaluation of telemedicine diabetic retinopathy examination using a non-mydriatic fundus camera in China].
    Fan JX; Zhang M; Zhao WY; Han Y; Hu WT; Jia HX; Sun XD
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):919-929. PubMed ID: 37936360
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
    Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
    Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
    Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
    PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
    Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
    Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
    Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
    Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
    Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
    Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation of fifteen cervical cancer screening strategies in rural China].
    Wang YY; Wang ZJ; Zhang Y; Gao XH; Yang CX; Zhao FH; Qiao YL; Ma L; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2019 Dec; 54(12):840-847. PubMed ID: 31874474
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
    van Katwyk S; Jin YP; Trope GE; Buys Y; Masucci L; Wedge R; Flanagan J; Brent MH; El-Defrawy S; Tu HA; Thavorn K
    Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-mydriatic fundus camera screening with diagnosis by telemedicine for diabetic retinopathy patients with type 1 and type 2 diabetes: a hospital-based cross-sectional study.
    Yaslam M; Al Adel F; Al-Rubeaan K; AlSalem RK; Alageel MA; Alsalhi A; AlNageeb D; Youssef AM
    Ann Saudi Med; 2019; 39(5):328-336. PubMed ID: 31580703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for diabetic retinopathy by non-mydriatic fundus photography: First national campaign in Lebanon].
    Arej N; Antoun J; Waked R; Saab C; Saleh M; Waked N
    J Fr Ophtalmol; 2019 Mar; 42(3):288-294. PubMed ID: 30857804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to Screen for Diabetic Retinopathy in Chinese Patients with Newly Diagnosed Type 2 Diabetes: A Cost-Effectiveness Analysis.
    Wu B; Li J; Wu H
    Medicine (Baltimore); 2015 Nov; 94(45):e1989. PubMed ID: 26559285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy screening programme utilising non-mydriatic fundus imaging in slum populations of New Delhi, India.
    Wadhwani M; Vashist P; Singh SS; Gupta N; Malhotra S; Gupta A; Shukla P; Bhardwaj A; Gupta V
    Trop Med Int Health; 2018 Apr; 23(4):405-414. PubMed ID: 29430785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling.
    Dorali P; Shahmoradi Z; Weng CY; Lee T
    Ophthalmol Retina; 2023 Jun; 7(6):532-542. PubMed ID: 36621610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
    Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
    Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of automated analysis of single-field non-mydriatic fundus photographs by Bosch DR Algorithm-Comparison with mydriatic fundus photography (ETDRS) for screening in undiagnosed diabetic retinopathy.
    Bawankar P; Shanbhag N; K SS; Dhawan B; Palsule A; Kumar D; Chandel S; Sood S
    PLoS One; 2017; 12(12):e0189854. PubMed ID: 29281690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
    Ben ÂJ; Neyeloff JL; de Souza CF; Rosses APO; de Araujo AL; Szortika A; Locatelli F; de Carvalho G; Neumann CR
    Appl Health Econ Health Policy; 2020 Feb; 18(1):57-68. PubMed ID: 31674001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.